About Our
Company

Nanolyx develops innovative, plant-based nanoparticle technology to provide powerful antimicrobial solutions without harming the environment. Our mission is to offer safe, sustainable alternatives to traditional disinfectants across various industries including healthcare, agriculture, and water treatment.

Meet the Founders

Leadership team

Robert Fletcher, MS

Interim CEO

Learn more about Robert

Robert Fletcher is a scientific researcher and entrepreneur in cleantech, holding a bachelor’s and master’s degree in Biochemistry and Biotechnology from the University of New Hampshire. With experience in the biopharmaceutical industry, Robert has advanced research in viral vector purification and oligo therapeutics for rare diseases. Since late 2023, he has served as co-founder and interim CEO of Nanolyx, an early-stage life science company developing eco-friendly antimicrobials to combat resistant microorganisms. Driven by a passion for sustainability and market innovation, Robert blends scientific expertise with entrepreneurial vision to drive impactful change.

Veer Shah, MD, MS

Scientific co-founder

Learn more about Veer

Veer is an integral cofounder and former CEO of Nanolyx and is also an MD candidate at the Icahn School of Medicine at Mount Sinai. Veer worked alongside Dr. David Medina Cruz in advancing R&D in the Green Chemistry lab, spearheaded commercialization efforts, and navigated accelerators like NSF I-Corps and the National Cleantech Open. His skills shine through exemplary leadership, negotiations with legal entities, technology transfer, and advancing strategic partnerships with academia and industry. Veer is passionate about helping the world realize the innovative potential of green nanotechnology to address global health challenges.

Darshi Shah, MD PhD

Business co-founder

Learn more about Darshi

Darshi is a cofounder and former COO of Nanolyx and is also an MD/MPH candidate at the Renaissance School of Medicine at Stony Brook University. She received her B.S. in biomedical engineering and a B.A. in biology from Boston University. Her team management, operative leadership, and bench-to-market acumen have been crucial to Nanolyx’s initial translational research and commercialization efforts. Darshi brings extensive startup experience and unique industry experience in strategically accelerating new technologies. At the core of her values, she is driven to scale promising medical technologies to improve the lives of the ones who need it the most.